Stimuli-Responsive (Smart) Drug Delivery Systems: An In-Depth Review

The emergence of stimuli-responsive drug delivery systems (SRDDS), often referred to as smart drug delivery platforms, represents a transformative leap in the field of pharmaceutical technology. By harnessing specific internal or external stimuli, these innovative systems offer the capability to release therapeutic agents in a controlled manner with high precision, targeting specific tissues or pathological sites. This targeted delivery approach not only maximizes drug efficacy but also substantially reduces adverse effects commonly associated with conventional therapies. In this comprehensive review, we explore the diverse categories of stimuli that can trigger drug release, including but not limited to pH variations, temperature changes, enzymatic activity, redox conditions, light, magnetic fields, and ultrasound. The discussion extends to the design principles underlying the construction of smart materials and Nano carriers capable of responding to these cues, emphasizing polymeric structures, lipid-based systems, inorganic nanoparticles, and hybrid assemblies. Detailed examination of drug release mechanisms reveals how these systems translate environmental changes into physicochemical responses that facilitate precise drug liberation. Additionally, the review highlights significant biomedical applications of SRDDS across various disease models, including cancer, neurological disorders, inflammation, and infectious diseases. Attention is also given to the recent advances in multifunctional platforms that combine diagnostic and therapeutic functions, often referred to as theranostics. Despite promising developments, several challenges remain, such as reproducibility, scalability, biocompatibility, regulatory approval, and clinical translation. This article concludes by outlining future directions, focusing on the integration of personalized medicine, advanced biomaterials, and smart manufacturing technologies to further refine and optimize SRDDS for widespread clinical use.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-08-14
DOI
https://doi.org/10.5281/zenodo.16872500
Primary Topic
Nanoparticle-Based Drug Delivery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Stimuli-Responsive (Smart) Drug Delivery Systems: An In-Depth Review

Zenodo (CERN European Organization for Nuclear Research)
Nanoparticle-Based Drug Delivery
article

Stimuli-Responsive (Smart) Drug Delivery Systems: An In-Depth Review

article en

Abstract

The emergence of stimuli-responsive drug delivery systems (SRDDS), often referred to as smart drug delivery platforms, represents a transformative leap in the field of pharmaceutical technology. By harnessing specific internal or external stimuli, these innovative systems offer the capability to release therapeutic agents in a controlled manner with high precision, targeting specific tissues or pathological sites. This targeted delivery approach not only maximizes drug efficacy but also substantially reduces adverse effects commonly associated with conventional therapies. In this comprehensive review, we explore the diverse categories of stimuli that can trigger drug release, including but not limited to pH variations, temperature changes, enzymatic activity, redox conditions, light, magnetic fields, and ultrasound. The discussion extends to the design principles underlying the construction of smart materials and Nano carriers capable of responding to these cues, emphasizing polymeric structures, lipid-based systems, inorganic nanoparticles, and hybrid assemblies. Detailed examination of drug release mechanisms reveals how these systems translate environmental changes into physicochemical responses that facilitate precise drug liberation. Additionally, the review highlights significant biomedical applications of SRDDS across various disease models, including cancer, neurological disorders, inflammation, and infectious diseases. Attention is also given to the recent advances in multifunctional platforms that combine diagnostic and therapeutic functions, often referred to as theranostics. Despite promising developments, several challenges remain, such as reproducibility, scalability, biocompatibility, regulatory approval, and clinical translation. This article concludes by outlining future directions, focusing on the integration of personalized medicine, advanced biomaterials, and smart manufacturing technologies to further refine and optimize SRDDS for widespread clinical use.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 61%
Nanoparticle-Based Drug Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Stimuli-Responsive (Smart) Drug Delivery Systems: An In-Depth Review · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS